Literature DB >> 24895392

Surgery and radiation therapy for brain metastases from classic biphasic pulmonary blastoma.

Kenta Kawasaki1, Kuniatsu Yamamoto2, Yoshio Suzuki3, Hirohisa Saito4.   

Abstract

Pulmonary blastoma, a rare malignant lung tumour, can metastasise to the brain. However, there is no evidence for any effective treatment. The aim of this report is to discuss the treatment options for pulmonary blastoma and confirm the necessity for a pathological diagnosis. A 75-year-old man was admitted with progressive right-sided hemiplegia and aphasia. MRI showed multiple brain tumours. A left frontal lobe lesion was surgically resected, after which he underwent whole brain radiation (30 Gy/10 fractions). He died of an acute exacerbation of interstitial pneumonia. On performing autopsy, partial responses in the brain metastases that had been irradiated were confirmed pathologically. Thus, we present pathological confirmation that surgery and radiation therapy have therapeutic effects on brain metastases from pulmonary blastoma. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24895392      PMCID: PMC4054495          DOI: 10.1136/bcr-2014-203990

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Classic biphasic pulmonary blastoma: a case report and review of the literature.

Authors:  S Van Loo; E Boeykens; I Stappaerts; R Rutsaert
Journal:  Lung Cancer       Date:  2011-04-21       Impact factor: 5.705

Review 2.  Solitary brain metastasis from classic biphasic pulmonary blastoma: a case report and review of the literature.

Authors:  John R Kouvaris; Penelope V Gogou; Xenofon N Papacharalampous; Helen J Kostara; Myrsini J Balafouta; Lambros J Vlahos
Journal:  Onkologie       Date:  2006-12-11

Review 3.  Pulmonary blastoma: a review with special emphasis on prognosis and treatment.

Authors:  H Larsen; J B Sørensen
Journal:  Cancer Treat Rev       Date:  1996-05       Impact factor: 12.111

Review 4.  Pulmonary blastoma: case report of a patient with a 7-year remission and review of chemotherapy experience in the world literature.

Authors:  C S Cutler; R P Michel; M Yassa; A Langleben
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

5.  Pulmonary blastoma: report of two cases.

Authors:  A Bini; L Ansaloni; G Grani; M Grazia; D Pagani; F Stella; R Bazzocchi
Journal:  Surg Today       Date:  2001       Impact factor: 2.549

6.  Pulmonary blastoma: medium-term results from a regional center.

Authors:  Afzal Zaidi; Vipin Zamvar; Fergus Macbeth; Allen R Gibbs; Nihal Kulatilake; Eric G Butchart
Journal:  Ann Thorac Surg       Date:  2002-05       Impact factor: 4.330

7.  Pulmonary blastoma.

Authors:  A J Barson; A W Jones; K V Lodge
Journal:  J Clin Pathol       Date:  1968-07       Impact factor: 3.411

8.  Evaluation of patients with advanced cancer using the Karnofsky performance status.

Authors:  J W Yates; B Chalmer; F P McKegney
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

9.  Pulmonary blastomas.

Authors:  M N Koss; L Hochholzer; T O'Leary
Journal:  Cancer       Date:  1991-05-01       Impact factor: 6.860

Review 10.  Pulmonary blastoma--a rare tumour.

Authors:  V Kliem; M Bügge; K Leimenstoll; H Maschek
Journal:  Clin Investig       Date:  1992-10
View more
  3 in total

Review 1.  Classic biphasic pulmonary blastoma with brain and axillary metastases: a case report with molecular analysis and review of literature.

Authors:  Yingjie Xiu; Lili Jiang; Weiping Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  What do we know about pulmonary blastoma?: review of literature and clinical case report.

Authors:  Dorota Brodowska-Kania; Ewa Kotwica; Aleksandra Paturej; Witold Sośnicki; Janusz Patera; Agnieszka Giżewska; Stanisław Niemczyk
Journal:  Nagoya J Med Sci       Date:  2016-12       Impact factor: 1.131

Review 3.  Classic biphasic pulmonary blastoma: a case report and review of the literature.

Authors:  Zhuanbo Luo; Chao Cao; Ning Xu; Kejing Ying
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.